These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-p-L-fluorophenylalanine ethyl ester) and P2 (L-prolyl-m-L-sarcolysyl-p-L-fluorophenylalanine ethyl ester): comparison with melphalan. Gullbo J; Dhar S; Luthman K; Ehrsson H; Lewensohn R; Nygren P; Larsson R Anticancer Drugs; 2003 Sep; 14(8):617-24. PubMed ID: 14501383 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): comparison with its m-L-sarcolysin analogue P2. Gullbo J; Wallinder C; Tullberg M; Lövborg H; Ehrsson H; Lewensohn R; Nygren P; Luthman K; Larsson R Mol Cancer Ther; 2003 Dec; 2(12):1331-9. PubMed ID: 14707274 [TBL] [Abstract][Full Text] [Related]
4. Derivatives of melphalan designed to enhance drug accumulation in cancer cells. Kupczyk-Subotkowska L; Tamura K; Pal D; Sakaeda T; Siahaan TJ; Stella VJ; Borchardt RT J Drug Target; 1997; 4(6):359-70. PubMed ID: 9239576 [TBL] [Abstract][Full Text] [Related]
5. Activity of hydrolytic enzymes in tumour cells is a determinant for anti-tumour efficacy of the melphalan containing prodrug J1. Gullbo J; Wickström M; Tullberg M; Ehrsson H; Lewensohn R; Nygren P; Luthman K; Larsson R J Drug Target; 2003 Jul; 11(6):355-63. PubMed ID: 14668056 [TBL] [Abstract][Full Text] [Related]
6. Antitumor efficacy and acute toxicity of the novel dipeptide melphalanyl-p-L-fluorophenylalanine ethyl ester (J1) in vivo. Gullbo J; Lindhagen E; Bashir-Hassan S; Tullberg M; Ehrsson H; Lewensohn R; Nygren P; De La Torre M; Luthman K; Larsson R Invest New Drugs; 2004 Nov; 22(4):411-20. PubMed ID: 15292711 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A. Baraldi PG; Romagnoli R; Beria I; Cozzi P; Geroni C; Mongelli N; Bianchi N; Mischiati C; Gambari R J Med Chem; 2000 Jul; 43(14):2675-84. PubMed ID: 10893305 [TBL] [Abstract][Full Text] [Related]
8. Bifunctional constructs of aspirin and ibuprofen (non-steroidal anti-inflammatory drugs; NSAIDs) that express antibacterial and alkylation activities. Bartzatt R; Cirillo SL; Cirillo JD; Donigan L Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):273-82. PubMed ID: 12533193 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure-activity relationship and biological evaluation of novel nitrogen mustard sophoridinic acid derivatives as potential anticancer agents. Li DD; Dai LL; Zhang N; Tao ZW Bioorg Med Chem Lett; 2015 Oct; 25(19):4092-6. PubMed ID: 26299348 [TBL] [Abstract][Full Text] [Related]
10. Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies. Baraldi PG; Beria I; Cozzi P; Geroni C; Espinosa A; Gallo MA; Entrena A; Bingham JP; Hartley JA; Romagnoli R Bioorg Med Chem; 2004 Jul; 12(14):3911-21. PubMed ID: 15210158 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of aromatic nitrogen mustard agents and analysis of their alkylation activity at physiological pH and temperature. Bartzatt R; Kasher L Physiol Chem Phys Med NMR; 2002; 34(2):103-17. PubMed ID: 12841328 [TBL] [Abstract][Full Text] [Related]
12. [Synthesis and antitumor activity of benzoic nitrogen mustard derivatives]. Luo W; Zhao YM; Wang YX; Xie SQ; Zhao J; Wang CJ Yao Xue Xue Bao; 2007 Dec; 42(12):1327-9. PubMed ID: 18338650 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients. Larsson R; Dhar S; Ehrsson H; Nygren P; Lewensohn R Br J Cancer; 1998 Aug; 78(3):328-35. PubMed ID: 9703278 [TBL] [Abstract][Full Text] [Related]
14. The alkylating prodrug J1 can be activated by aminopeptidase N, leading to a possible target directed release of melphalan. Wickström M; Viktorsson K; Lundholm L; Aesoy R; Nygren H; Sooman L; Fryknäs M; Vogel LK; Lewensohn R; Larsson R; Gullbo J Biochem Pharmacol; 2010 May; 79(9):1281-90. PubMed ID: 20067771 [TBL] [Abstract][Full Text] [Related]
15. A new class of cytotoxic DNA minor groove binders: alpha-halogenoacrylic derivatives of pyrrolecarbamoyl oligomers. Cozzi P Farmaco; 2001; 56(1-2):57-65. PubMed ID: 11347968 [TBL] [Abstract][Full Text] [Related]
16. Bivalent bendamustine and melphalan derivatives as anticancer agents. Scutaru AM; Wenzel M; Gust R Eur J Med Chem; 2011 May; 46(5):1604-15. PubMed ID: 21371790 [TBL] [Abstract][Full Text] [Related]
17. Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards. Godenèche D; Madelmont JC; Moreau MF; Plagne R; Meyniel G Cancer Chemother Pharmacol; 1980; 5(1):1-9. PubMed ID: 7460189 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and alkylation activity of a nitrogen mustard agent to penetrate the blood-brain barrier. Bartzatt RL Drug Deliv; 2004; 11(1):19-26. PubMed ID: 15168787 [TBL] [Abstract][Full Text] [Related]
19. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents. Coley HM; Mongelli N; D'Incalci M Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762 [TBL] [Abstract][Full Text] [Related]
20. Sequence-specific DNA alkylation of novel tallimustine derivatives. Marchini S; Cozzi P; Beria I; Geroni C; Capolongo L; D'Incalci M; Broggini M Anticancer Drug Des; 1998 Apr; 13(3):193-205. PubMed ID: 9595033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]